Clinical Trials Directory

Trials / Completed

CompletedNCT00182923

Forearm Vascular Relaxation

Determinants of Forearm Vascular Relaxation: Role of Genetic Polymorphisms

Status
Completed
Phase
Study type
Observational
Enrollment
400 (planned)
Sponsor
National Institute on Aging (NIA) · NIH
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to learn the effect of inherited differences on forearm blood flow responses to hormones and drugs

Detailed description

Differences in at least 4 genes are believed to have an important effect on responses to hormones and drugs. For this study, healthy volunteers of normal body weight will be screened to find xxx individuals with the genes of interest. Very small doses of hormones and drugs will be given so that changes in forearm blood flow can be measured, while not causing effects throughout the body. A brachial artery line and venous line will be placed in the study arm so that blood samples may be withdrawn to compare amounts given into the artery and coming out of the vein after circulating through the arm. Forearm blood flow is determined by the rate of swelling of the arm after a blood pressure cuff is inflated (above venous and below arterial blood pressure). The hormones and drugs being studied include angiotensin I, angiotensin II, acetylcholine, sodium nitroprusside, enalaprilat, L-arginine, phenylephrine, endothelin-1, verapamil, and isoproterenol. This procedure will last 4-6 hours. The process will be repeated with the same participant over 2 weeks later.

Conditions

Timeline

Start date
2003-05-01
Primary completion
2006-12-01
Completion
2006-12-01
First posted
2005-09-16
Last updated
2008-08-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00182923. Inclusion in this directory is not an endorsement.